Fujitsu Honored by the International Headache Society
TOKYO, Mar 2, 2022 – (JCN Newswire via SEAPRWire.com) – Fujitsu today announced that it was the first company in the world to be honored by the Global Patient Advocacy Coalition of the International Headache Society(1)(IHS-GPAC) as a world leader in migraine workplace awareness, education, and employee support programs. Figure 1: Accreditation from IHS-GPAC to... » read more
Avance Clinical Client News: XWPharma Initiates First-in-Human Studies of XW10508, in Development for Fast-acting Relief of Treatment-Resistant Depression and Chronic Pain
ADELAIDE, AUS, Oct 19, 2021 – (ACN Newswire) – Avance Clinical, the largest premium Australian CRO for international biotechs, is pleased to share the news that its client XWPharma Ltd. has announced dosing of subjects in its first-in-human study evaluating XW10508, the Company’s novel, patented, glutamatergic NMDA antagonist and AMPA activator in development as an oral, once-daily therapy for... » read more
Heart patients with diabetes more likely to suffer complications and death: Study
SINGAPORE – People with chronic heart disease who also have diabetes are at higher risk of death and have poorer outcomes than heart patients who do not also have diabetes, according to an international study that tracked heart patients on a registry over five years. It found that patients who had both diabetes and chronic... » read more